16 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
IONS Ionis Pharmaceuticals, Inc. $48.21 $6.62B N/A
Article Searches
Achillion's Danicopan Gets Breakthrough Therapy Tag for PHN http://www.zacks.com/stock/news/537115/achillions-danicopan-gets-breakthrough-therapy-tag-for-phn?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-537115 Sep 26, 2019 - Achillion's (ACHN) oral factor D inhibitor, danicopan, receives Breakthrough Therapy designation from the FDA as a treatment option for PNH. Shares up.
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release http://www.zacks.com/stock/news/592808/ionis-pharmaceuticals-ions-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q3-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-592808 Oct 30, 2019 - Ionis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ion Geophysical (IO) Reports Q3 Loss, Tops Revenue Estimates http://www.zacks.com/stock/news/594179/ion-geophysical-io-reports-q3-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-594179 Oct 30, 2019 - Ion Geophysical (IO) delivered earnings and revenue surprises of 46.15% and 22.67%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
ION Geophysical Corporation (IO) CEO Chris Usher on Q3 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4302014-ion-geophysical-corporation-io-ceo-chris-usher-q3-2019-results-earnings-call-transcript?source=feed_sector_transcripts Nov 03, 2019 - ION Geophysical Corporation (NYSE:IO) Q3 2019 Earnings Conference Call October 31, 2019 10:00 ET Company Participants Rachel White - Vice President, Corporate Communications Chris Usher - President an
Ionis Pharmaceuticals, Inc. (IONS) CEO Stanley Crooke on Q3 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4303447-ionis-pharmaceuticals-inc-ions-ceo-stanley-crooke-q3-2019-results-earnings-call-transcript?source=feed_sector_healthcare Nov 06, 2019 - Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2019 Earnings Conference Call November 6, 2019 11:30 A.M. ET Company Participants Wade Walke - Vice President, Investor Relations Stan Crow - Chairman of t
Master plan for Ion and Innovation District at former Midtown Sears site revealed https://www.chron.com/business/prime-property/article/The-Ion-former-Midtown-Sears-and-Innovation-14826265.php Nov 11, 2019 -

Documents filed with the city show a proposed site plan for the Ion and 15-acre South Main Innovation District comprising multiple blocks along and east of Main Street. The plan shows 13 proposed new structures, greenspace and a "Central Laneway" stretching from Main to Caroline.

Surging Earnings Estimates Signal Upside for Ionis Pharmaceuticals (IONS) Stock http://www.zacks.com/stock/news/629343/surging-earnings-estimates-signal-upside-for-ionis-pharmaceuticals-ions-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-629343 Nov 20, 2019 - Ionis Pharmaceuticals (IONS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Biogen's New Study to Test Higher Dose of SMA Drug Spinraza http://www.zacks.com/stock/news/526375/biogens-new-study-to-test-higher-dose-of-sma-drug-spinraza?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-526375 Sep 19, 2019 - Biogen (BIIB) starts a DEVOTE study to investigate whether a higher dose of Spinraza can provide greater efficacy for treating patients with spinal muscular atrophy.
A Biotech Set to Dominate the Next 20 Years https://www.fool.com/investing/2019/10/01/3-stocks-set-to-dominate-the-next-20-years.aspx?source=iedfolrf0000001 Oct 01, 2019 - Ionis Pharma has some powerful numbers now. But its future opportunities are even more amazing.
3 win Nobel in Chemistry for work on lithium-ion batteries https://www.ocregister.com/2019/10/09/3-win-nobel-in-chemistry-for-work-on-lithium-ion-batteries/ Oct 09, 2019 - STOCKHOLM (AP) — Three scientists won the Nobel Prize in Chemistry on Wednesday for their work developing lithium-ion batteries, which have reshaped energy storage and transformed cars, mobile phones and many other devices — and reduced the world's reliance on fossil fuels that contribute to global warming.

Pages: 12

Page 1